Related Experiment Video
Updated: Jul 16, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Multiple Antibiotic Allergy Evaluation Strategy (MAAES): A Comparative Effectiveness Study
Thanaporn Ratchataswan1, Rebecca Lee2, Amir Asiaee3
1Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn.
Background:
Inaccurate multiple antibiotic allergy labels to first-line agents (penicillins, cephalosporins, and sulfonamides) restrict optimal therapy and often require sequential evaluations across multiple visits, delaying delabeling and increasing loss to follow-up.
Objective:
To conduct a comparative effectiveness study of the Multiple Antibiotic Allergy Evaluation Strategy (MAAES), comparing its effectiveness, safety, and patient-reported outcomes (PRO) with traditional sequential evaluation (non-MAAES).
Methods:
This retrospective cohort study (2014-2024) compared same-day multi-antibiotic testing (MAAES) with non-MAAES in patients with 2 or more low-risk labels. Multivariable regression adjusted for baseline differences and testing era. Inverse probability of treatment weighting (IPTW) and a restricted post-2020 subcohort analysis addressed selection bias and temporal shifts. Outcomes included delabeling efficacy, time to complete delabeling, loss to follow-up, relabeling, adverse events (AEs), and PRO.
Results:
Baseline differences were present between the MAAES and non-MAAES groups, including penicillin anaphylaxis (1.4% vs 6.6%, P = .002), angioedema (12.4% vs 19.1%, P = .049), maculopapular rash (13.1% vs 24.3%, P = .002), and unknown sulfonamide history (9.5% vs 3.7%, P = .03). MAAES removed 97.4% of labels versus 79.6% for non-MAAES (adjusted odds ratio [aOR]: 9.41, 95% confidence interval [CI]: 5.22-16.95, P < .001). MAAES achieved faster complete delabeling (log-rank χ2 = 42.4, P < .001), with 84.9% versus 21.1% delabeled at the initial visit (restricted mean survival time difference: 2.1 months). Results remained robust in post-2020 and IPTW models. Loss to follow-up (1.3% vs 17.2%; aOR: 0.06, 95% CI: 0.03-0.13, P <.001) and AEs (<1% vs 2.8%; aOR: 0.26, 95% CI: 0.09-0.78, P = .02) were significantly lower with MAAES. Favorable PRO was sustained, with no significant differences between groups.
Conclusions:
A consolidated multidrug evaluation strategy substantially improves the effectiveness of first-line antibiotic allergy delabeling while maintaining excellent safety profiles and PRO.
Insights
The Multiple Antibiotic Allergy Evaluation Strategy (MAAES) significantly improves antibiotic allergy delabeling rates and speed compared to traditional methods. This approach enhances patient safety and reduces follow-up loss, proving more effective for antibiotic allergy assessment.
Area of Science:
- Clinical immunology
- Pharmacology
- Infectious diseases
Background:
- Inaccurate antibiotic allergy labels to first-line agents like penicillins and cephalosporins impede optimal treatment.
- Sequential evaluations for delabeling are time-consuming, leading to delayed care and patient drop-off.
Purpose of the Study:
- To compare the effectiveness, safety, and patient-reported outcomes (PRO) of the Multiple Antibiotic Allergy Evaluation Strategy (MAAES) against traditional sequential evaluation (non-MAAES).
Main Methods:
- A retrospective cohort study (2014-2024) compared same-day multi-antibiotic testing (MAAES) with non-MAAES in patients with multiple low-risk allergy labels.
- Statistical analyses included multivariable regression and inverse probability of treatment weighting (IPTW) to adjust for baseline differences and bias.
Main Results:
- MAAES achieved a significantly higher delabeling rate (97.4% vs. 79.6%) and faster delabeling (84.9% at initial visit vs. 21.1%).
- MAAES demonstrated lower rates of loss to follow-up (1.3% vs. 17.2%) and adverse events (<1% vs. 2.8%).
- Patient-reported outcomes were comparable between MAAES and non-MAAES groups.
Conclusions:
- A consolidated multi-drug evaluation strategy, MAAES, substantially enhances the effectiveness of first-line antibiotic allergy delabeling.
- MAAES maintains excellent safety profiles and positive patient-reported outcomes.
- This strategy offers a more efficient and effective approach to managing antibiotic allergy labels.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Urine Studies II: Urine Culture and Sensitivity Test
Antimicrobial Effectiveness
Clinical Significance of Antibiotic Resistance
Antibiotic Selection
Bioavailability Study Design: Single Versus Multiple Dose Studies